PPARδ agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-09. Numbers and descriptions here follow the published literature rather than marketing material.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
== Early life == The daughter of Michael and Bonita Pressdee, she was born on August 28, 1982, and is the oldest of two children. From 2003 to 2004, she attended the Community College of Allegheny County but did not graduate. She later became a registered veterinary technician before returning to obtain a nursing degree.
The Conservative Party under the leadership of Margaret Thatcher won the 1979 general election, placing the Labour Party back in opposition, which served to push the Liberals back into the margins. In 1981, defectors from a moderate faction of the Labour Party, led by former Cabinet ministers Roy Jenkins, David Owen, Shirley Williams and Bill Rodgers founded the Social Democratic Party (SDP). The new party and the Liberals quickly formed the SDP–Liberal Alliance, which for a while polled as high as 50% in the opinion polls and appeared capable of winning the next general election. Indeed, Steel was so confident of an Alliance victory that he told the 1981 Liberal conference, "Go back to your constituencies, and prepare for government!". However, the Alliance was overtaken in the polls by the Tories in the aftermath of the Falkland Islands War and at the 1983 general election the Conservatives were re-elected by a landslide, with Labour once again forming the opposition. While the SDP–Liberal Alliance came close to Labour in terms of votes (a share of more than 25%), it only had 23 MPs compared to Labour's 209. The Alliance's support was spread out across the country, and was not concentrated in enough areas to translate into seats. In the 1987 general election, the Alliance's share of the votes fell slightly and it now had 22 MPs. In the election's aftermath Steel proposed a merger of the two parties. Most SDP members voted in favour of the merger, but SDP leader David Owen objected and continued to lead a "rump" SDP.
Chemicals abandoned at the plant continue to leak and pollute the groundwater. Whether the chemicals pose a health hazard is disputed. Contamination at the site and surrounding area was not caused by the gas leakage. The area around the plant was used as a dumping ground for hazardous chemicals and by 1982 water wells in the vicinity of the UCIL factory had to be abandoned. UCC states that "after the incident, UCIL began clean-up work at the site under the direction of Indian central and state government authorities". The work was continued from 1994 by Eveready Industries India, Limited (EIIL) who was UCIL's successor. In 1998, the Madhya Pradesh State Government, which owned and had been leasing the property to EIIL, cancelled the lease, took over the facility and assumed all accountability for the site, including the completion of any remediation. UCC's laboratory tests in 1989 revealed that soil and water samples collected from near the factory were toxic to fish. Twenty-one areas inside the plant were reported to be highly polluted. In 1991 the municipal authorities declared that water from over 100 wells was hazardous for health if used for drinking. In 1994 it was reported that 21% of the factory premises were seriously contaminated with chemicals. Beginning in 1999, studies made by Greenpeace and others from soil, groundwater, well water and vegetables from the residential areas around UCIL and from the UCIL factory area show contamination with a range of toxic heavy metals and chemical compounds.
== Research == In April 2014, the American Academy of Neurology found evidence supporting the effectiveness of the cannabis extracts in treating certain symptoms of multiple sclerosis and pain, but there was insufficient evidence to determine effectiveness for treating several other neurological diseases. A 2015 review confirmed that medical marijuana was effective for treating spasticity and chronic pain, but caused numerous short-lasting adverse events, such as dizziness.
Sources: en.wikipedia.org
In August 2019, the FDA approved fedratinib (Inrebic) as a treatment for adults with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). In March 2022, the FDA approved pacritinib (Vonjo) with an indication to treat adults who have intermediate or high-risk primary or secondary myelofibrosis and who have platelet (blood clotting cells) levels below 50,000/μL. Momelotinib (Ojjaara) was approved for medical use in the United States in September 2023. It is indicated for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis [post-polycythemia vera and post-essential thrombocythemia], in adults with anemia. Currently a few drugs are under clinical trial for their use in myelofibrosis. This includes Tasquinimod, which targets the alarmin protein S1009a and has been shown to have beneficial effects in pre-clinical models.
== Notable people with Alport syndrome == Sam Clarke, British filmmaker Shae Hutchinson, Norwich City Football Club Under-23's player Christopher Kelsall, drummer for band Mirrortalk Ellie Kugler, American Kidney Fund ambassador and bodybuilder
== Nitrogen-15 == Nitrogen-15 is a rare stable isotope of nitrogen, comprising about 0.38%. Nitrogen-15 presents one of the lowest thermal neutron capture cross sections of all isotopes. Nitrogen-15 is frequently used in NMR (Nitrogen-15 NMR spectroscopy). Unlike the more abundant nitrogen-14, which has an integer nuclear spin and thus a quadrupole moment, 15N has a fractional nuclear spin of one-half, which offers advantages for NMR such as narrower line width. As most nitrogen NMR studies look at a single nitrogen atom in an organic molecule, isotopic labeling is feasible. Nitrogen-15 tracing is a technique used to study the nitrogen cycle.
=== Relapsing-remitting MS === Medications are modestly effective at decreasing the number of attacks in relapsing-remitting multiple sclerosis and in reducing the accumulation of brain lesions, which is measured using gadolinium-enhanced magnetic resonance imaging (MRI). Interferons reduce relapses by approximately 30% and their safe profile make them the first-line treatments. Nevertheless, not all the patients are responsive to these therapies. It is known that 30% of MS patients are non-responsive to Beta interferon. They can be classified in genetic, pharmacological and pathogenetic non-responders. One of the factors related to non-respondance is the presence of high levels of interferon beta neutralizing antibodies. Interferon therapy, and specially interferon beta 1b, induces the production of neutralizing antibodies, usually in the second 6 months of treatment, in 5 to 30% of treated patients. Moreover, a subset of RRMS patients with specially active MS, sometimes called "rapidly worsening MS" are normally non-responders to interferon beta 1a. While more studies of the long-term effects of the drugs are needed, existing data on the effects of interferons indicate that early-initiated long-term therapy is safe and it is related to better outcomes.
Nuclear pharmacy focuses on preparing radioactive materials for diagnostic tests and for treating certain diseases. Nuclear pharmacists undergo additional training specific to handling radioactive materials, and unlike in community and hospital pharmacies, nuclear pharmacists typically do not interact directly with patients.
Sources: en.wikipedia.org
=== American Cancer Society === Inhorn's ongoing interest in cervical cancer was the reason that he joined the American Cancer Society, Wisconsin Division, in 1967. He was Chair of the State Cancer Prevention Study II, and in 1986, he headed a demonstration project with a number of Wisconsin hospitals to determine the acceptance of offering low-cost mammography as a screening test for breast cancer. Inhorn served as President of the Wisconsin Division from 1970 to 1972, continuing on the board until 2010. He also served on the national American Cancer Society Board from 1982 to 1990.
== The war years == What was meant to be a short stay in the US turned into a much longer one as a result of World War II. Switzerland, ringed by hostile forces, advised Hofmann, an officer in the Swiss militia, not to return for the course of the war. He spent the war years working as a guest at Ciba Pharmaceutical Company in New Jersey. From there he moved to the University of Pittsburgh at a time when the institution was trying to build a research reputation.
== Legality == Brorphine is not controlled under the Single Convention on Narcotic Drugs, 1961, or under the Federal Analogue Act, but it could be illegal to sell, produce, possess or consume it in several countries if it is sold for human consumption. In the United States, brorphine was placed into temporary emergency Schedule I for 2 years by the DEA on January 4, 2021. On February 3, 2023, the DEA filed plans in the Federal Register for permanent placement of brorphine into Schedule I.
Brazil, officially the Federative Republic of Brazil, is the largest country in South America. It is also the world's fifth-largest country by area and the seventh-largest by population, with over 214 million people. Brazil is a federation composed of 26 states and a Federal District, which hosts the capital, Brasília. Its most populous city is São Paulo, followed by Rio de Janeiro. Brazil has the largest Lusophone population in the world and is the only Portuguese-speaking country in the Americas, where it is the official language. Bounded by the Atlantic Ocean on the east, Brazil has a coastline of 7,491 kilometers (4,655 mi), among the longest in the world. Covering roughly half of South America's land area, it borders all other countries and territories on the continent except Ecuador and Chile. Brazil encompasses a wide range of tropical and subtropical landscapes, as well as wetlands, savannas, plateaus, and low mountains. It contains most of the Amazon basin, including the world's largest river system and most extensive virgin tropical forest. Brazil has diverse wildlife, a variety of ecological systems, and extensive natural resources spanning numerous protected habitats. It ranks first among 17 megadiverse countries, with its natural heritage being the subject of significant global interest, as environmental degradation (through processes such as deforestation) directly affect global issues such as climate change and biodiversity loss. Brazil was inhabited by various indigenous peoples prior to the landing of Portuguese explorer Pedro Álvares Cabral in 1500.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.